Radiomic Signatures Associated with CD8(+) Tumour-Infiltrating Lymphocytes: A Systematic Review and Quality Assessment Study

SIMPLE SUMMARY: Immune checkpoint inhibitors can be effective drugs to treat cancer. However, only a minority of patients derive benefits. An important determinant of treatment success is the abundance of CD8-expressing tumour-infiltrating lymphocytes (CD8(+) TILs) in target tumours. The measurement...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramlee, Syafiq, Hulse, David, Bernatowicz, Kinga, Pérez-López, Raquel, Sala, Evis, Aloj, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367613/
https://www.ncbi.nlm.nih.gov/pubmed/35954318
http://dx.doi.org/10.3390/cancers14153656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367613/
https://www.ncbi.nlm.nih.gov/pubmed/35954318
http://dx.doi.org/10.3390/cancers14153656

Ejemplares similares